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Several papillomas from a single patient who exhib-
ited an unusual immune deficiency syndrome were ana-
lyzed for the presence of specific human papillomavirus 
(HPV) types. Preliminary analysis indicated that the 
HPV DNA species present in each of these tissues was 
quite unlike any of the previously characterized HPV 
types. In order to more rigorously analyze the HPV from 
this patient we have isolated the HPV DNA by molecu-
larly cloning it into a bacteriophage lambda vector and 
have constructed a detailed restriction endonuclease 
map; Comparative hybridization studies using S1 nu-
clease analyses showed 6% or less nucleotide sequence 
homology of this viral DNA with HPV types 1, 2, 3, 4, 
5, 6, or an HPV -11, molecularly cloned in this labora-
tory. Moreover, Southern blot analyses under stringent 
hybridization conditions revealed little, if any, hybrid-
ization to HPV types 1, 2, 4, 5, 7, 8, 10, 11, HPV-EV 
isolated from a patient with epidermodysplasia verru-
ciformis (EV) , or 2 previously described HPVs (HPV-P 
and HPV-PW) related to HPV-3. There was, however, 
a very weak sequence homology detected with HPV -6 
and an extremely weak homology to HPV-3. No filter 
hybridization was observed with the recently character-
ized HPVs 9 or -12 to -24. These data accumulatively 
indicate that the HPV species from this immunosup-
pressed patient represents a new, hitherto unidentified 
HPV type. 
While on ly a handful of apparent ly benign human papillo-
maviruses (HPV) are found in the general population, many 
variants have recently been identitied in patients with immune 
deficienci es. Some of these rare and unusual HPVs seem also 
to have some oncogenic potential based upon their close asso-
ciation with some malignant tissues. Human papillomavirus 
type 5 (HPV-5) has been found to be associated with both 
benign and malignant tu mors of pat ients with epidermodyspla-
s ia verruciformis (EV) [1- 3], as has HPV-EV in urogenital 
ca rcinomas [ 4], HPV -6 in invasively growing condylomata ac-
cuminata [5], and HPV-11 with verrucus ca rcinoma [6] (also 
see below). HPV-6 a nd HPV-11 have both been found in some 
cervi cal can ce rs as well (7] . HPV -5 a lso has the abi lity to 
t ra nsform mouse cell s in vitro and form tumors in athymic 
nude mice.* Moreover, a large proportion of cervical and vaginal 
dysplasia have HPV involvement [8- 10]. This evidence points 
strongly to an etiologic ro le of some HPVs in human neoplasias. 
While not a ll HPV types are associated with malignancy, the 
incidence of papillomas a nd associated malignancies is partie-
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ularly marked in patients who are immunologically compro-
mised as in t hose having EV [2,11,12] and renal transp lant 
patien ts [13,14]-i' We have been involved in an ongoing study 
in which various tissues from patients with distinct medical 
histories a re examined for the presence of HPV nucleotide 
sequences. In an effort to begin to understand the biology of 
these viruses, detected HPV DNAs are then characterized with 
respect to known HPV types. During the course of these studies 
we examined 4 papillomas from a single patient with an unusuai 
immune deficiency, multiple carcinomas, and other viral infec-
tions. We report here the molecular cloning and characteriza-
tion of a novel HPV DNA isolated from th is patient. 
PATIENT HISTORY 
Patient RCM is a 53-yea r-old heterosexual Caucasian male wi th 8 
2-year histo ry of eruptive ver ruca vulgaris and condylomata. He also 
has a history of multiple squamous cell carcinomas of the face and 
forehead first. diagnosed in 1972 and treated with x-rays from 1977 to 
.June of 1982. Approximately in 1980 seve ral cutaneous infections 
appea red. Skin exa mination revealed multiple erythematous, hyperker-
atotic lesions on the fa ce, forehead, and dorsa of the hands (Fig 1a). 
The lesions on the forehead were consistent wi th actinic keratoses. 
The lesions on the hands were multiple verrucae. There were al 0 
ve rrucae on the planta r aspect of the right foot. Groin examination 
revealed extensive maceration on an erythematous base, pustules 
scattered erythematous papules, and hyperkeratotic plaques along the 
medial aspect of the upper th igh and the distal intert riginous groin 
area (Fig lb, c). There was a marked amount of a purulent yellowish-
green disc harge around the hyperkeratotic plaques. KOH of the groin 
was negat ive on admission . There were also marked erythematous. 
sca ly plaques on the abdomen, some with annular configuration. KO H 
of' the annu lar lesions was positive for hyphae. There was maceration 
of the toe webs which also showed fungal hyphae on KOH exam. Over 
the upper back and lowe r abdomen were many small, umbilicated 
papules co nsist.enl with molluscum contagiosum. The patient does nOt 
have Kaposi's sarcoma nor had he received any blood transfusions 
prior t.o treatment for the above conditions. Biopsy specimens for 
molecular studies were ve rruca vulgaris from t.he plantar aspect of the 
right foot and the dorsal aspect of the right fourth finge r, and condy-
loma accuminat.a of the right and left. medial thighs. 
Admission CBC revealed a hemoglobin of 9.2 g% (nl , 11.0- 15.0). 
hematocri t. of 28% (n l, 35 .0- 45.0), MCY of 77.9 J.lm" (nl, 75 .0- 85.0). 
and MCH of 25.6 pg (n l, 24.0- 28.0). Random SMA6 with creatin ine 
was essent ially within normal limits and SMA 12 revealed a slightly 
low prote in or 5.8 g/dl (nl , 6.0- 8.0) , albumin of 3.4 g/dl (nl, 3.8- 5.0), 
and a random glucose or 104 mg/dl (nl , 60- 100) but was otherwise 
within normal limits. Reticulocyte count upon admission was 1.1 and 
serum iron and tota l iron binding capacity were markedly low, 5 and 
151 1-' g/dl (nl , 35- 178 and 254 - 466), respectively. Rapid plasma reagent 
(RPR) was not reactive. Urinalysis was within normal limits and blood 
cul tures showed no growth. Virus cultures obtained from the intertri-
ginous lesions of the groin were positive for herpes simplex virus. 
Screen ing for hepatitis B was negative. Serum immunoglobulin re-
1G2 
1- K Zachow et al, manusc ript in preparation. 
Abbrev iations: 
EY: epidermodysplas ia verruciformis 
1-!PV: human papillomavirus 
LIF: Leukocyte inhibi tory factor 
nl: normal limit.(s) 
SDS: sod ium dodecyl sulfate 
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veale d a norma l JgG and lgA but slightly decreased lgM of 37.8 (nl , 
56-352). Direct Coombs was negat ive. Wedge biopsy from the inte rtri -
ginou s area o f t he groin showed cha nges consistent with he rpes virus 
infectio n . Chest x-ray revealed mild cardiomegaly but no specific ade-
nopath y. CT of the abdomen revealed a slight sple nomega ly, absent 
left kidney (a co ngenita l condition), and 2 bladder diverti culi , but did 
not r e veal a ny periaorti c adenopathy. Direct immunoiluorescence ex-
am inatio n of a biopsy from the inte rt riginous a rea was negative for all 
imm unogobulins a nd complement. Bone marrow exa mina tion revealed 
gran ul ocytic and megaka ryocytic hyperplasia but was otherwise unre-
marka bl e. Immunologic pa ramete rs included active rose tting of 28% 
(nl, 36%), tota l rosettes of 53% (nl , 60%), suppressor rosettes by t he 
Raj i cell me t hod of 3% (nl , 35%) indicating low levels of tota l a nd 
inte ractive T ce ll s . T -cell delinia tion by Leu 2 a nd Leu 3 revealed a 
low h e lper to suppresso r ratio of 1.35. (Afte r treatments which included 
bath s, Zovirax ointment, a nd tra ns fe r factor, the patient was lost. to 
fo llow -up for severa l months at which t.ime he was readmi tted for 
t reatment with a Leu 2 to Leu 3 T -cell ratio of 0.4 9. ) DNA synthesis 
fo llow in g mitogenic stimulation wi t h both phyto hemagglutinin (PHA ) 
and concanava lin A revealed a reduced response, and leukocyte inhib-
ito ry factor (L!F) production (lymphokines ) to PHA a nd PPD and 
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Ft G l. Clinica l appeara nce o f pm ient. a. Mul t iple ve rruca on act.in -
ica lly da maged skin of ha nds. b, ln t raglut.ea l crease wi t h nec roti zing 
recurre nt he rpes s implex and pink to ery themawus, moist. kera totic 
co ndyloma. c, Pe ria na l a rea with vegetacondyloma. 
Ca ndida were a ll negative. Except fo r t he extent of the wa rts, t hey 
appea red clinica lly norma l. Howeve r, histology was not perfo rmed at. 
t he time o f biopsy a nd the pa tien t. is not currently ava ilab le for further 
study. In a ny event , histology may have been diffi cul t to inte rpret due 
t.o t.he seve ra l types of simul ta neous skin in fect ions present . Clini ca l 
photogra phs of the pa t ient appear in Fig 1. Based upon symptoms, it 
would appear that. the immune defi ciency probably began o r a t least 
was present by 1980, 2 yea rs prio r to our rigo rous diagnostic studies. 
MATERIALS AND METHODS 
DNA Ext ract ion 
T ota l ce ll DNA was extracted as described previously [1 ]. Briefl y, 
ti ssue was treat ed wi t h sodium dodecyl sulfa te (S DS) -pronase at 6o·c 
fo r 30 min a nd then fully digested at. 37·c followed by the addi t ion of 
potass ium aceta te to 1.4 M a t 4•C. Afte r clearing, t he DNA in the 
supernata nt. was concent rated by the addi t ion of etha nol a nd t reated 
with RNase A followed by SDS-pronase digestion, phenoi-CH CI:. (I :1; 
vf v ) a nd C HCI:. extraction, a nd finall y ethanol precipit ation. 
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M olecular Clanin{( of Viral DNA 
Total ce ll DNA and lambda phage Charon 27 DNA were each cleaved 
with Bam HI restriction endonuclease, ligated, packaged in vitro and 
scree ned by filter hybridization under conditions of lowered stringency 
[l 5[ with labeled HPV-6 DNA as described previously [6). Amplified 
viral DNA was separated from the vector DNA by cleavage with Bam 
HI followed by 2 rounds of sucrose gradient (l M NaCI, 20 mM Tris-
HCI pH 7.4, 5 mM EDTA, 2 J.<f{/ ml ethidium bromide; 10- 40% sucrose; 
SW 27 rotor; 26K rpm; 24 h at 4 oC) ce ntrifugation. Following extraction 
with water-saturated butanol, t he purified DNA was concentrated with 
ethanol [16]. 
Restriction Endonuclease Analysis 
Treatment of DNA with restriction endonucleases, followed by aga-
ruse gel electrophoresis and t ransfer to ni trocellulose filters were per-
fo rmed as desc ribed previously [1] . 
IJ NA: /JNA Hy bridization 
Pi lte rs were hybridized by incubation in solutions conta ining 50% 
formam ide plus 10% dextran sulfate (high stringency) or 30% form -
amide plus IO% dex tran sulfate (low stringency) as described previously 
[l ] . 
In order to determine the extent of hybridiza tion , liquid hybridiza-
tion fo llowed by Sl nuclease analysis were performed as described 
previously [17]. Molecularly cloned viral DNAs were separated from 
the clon in g vector by treatment with the approp riate restriction endo-
nuclease, denawrcd by heating at 100· c for 5 min, and incubated in 
the prese nce of a heat-denatured, nick-translated DNA [I 1 in 0.6 M 
NaC I, 40 mM Tris-1-l CI pH 7.2, and 2 mM EDTA at 6s•c for 2 h to a 
Cot (DNA cone x time in mol ·s/li te r) value of 1.0. Samples were then 
analyzed for degree of renaturation to the labeled probe by treatment 
with S l nuclease followed by acid precipi ta tion. DNA probes were 10-
15% double -stranded ini tia lly and hybridized to a maximum of 63-73% 
with the positive control DNAs. 
RESULTS 
Total DNA extracts from 4 papillomas from patient RCM 
were a na lyzed for the presence of HPV DNA sequences by 
nitrocellulose filte r hybridization under stringen t conditions 
with severa l standard HPV DNAs. Little or no hybridization 
was observed with labeled HPV -1-2, -4, or -5 (data not shown). 
However, native, un in Legrated HPV DNA was detected in each 
o f th e t issue samples with labeled HPV -6 and to a lesser degree 
with labeled HPV -3 (Fig 2). The possibility that both of these 
HPVs might be present was tested by treating a sample with a 
combination of t he restriction endonucleases Bam HI and Hind 
III followed by ge l electrophoresis and stringent filter hybridi-
zation to HPV -6 and HPV -3 (Fig 2). In each case 3 identica l 
vira l DNA bands were detected, although hybridization was 
much less in te nse with labeled HPV-3, indicating that only a 
single viral DNA was present. 
It was, however, noted that t he intensity of the bands de-
tected even with labeled HPV -6 was far less than we would 
have expected from the amount of viral DNA observed by 
ethidium bromide sta ining of these electrophoretic gels. Assum-
ing that the HPV detected in t his patient was only distantly 
re lated to HPV -6, we undertook the molecular cloning of its 
DNA so t hat further characterization could proceed. We 
achieved this objective by t reating total cellular DNA with Bam 
HI, a restrict ion endonuclease which cleaved t his HPV DNA 
at a unique site (R. Ostrow, unpublished observation), and then 
ligating the HPV DNA with C haron 27 lambda phage DNA 
treated with the same enzyme. Following in vitro phage pack-
aging and screen ing of plaques by filter hybridjzation to labeled 
HPV -6 under less s tringent hybridization condi t ions, molecu-
la rly cloned viral DNA, hereafter referred to as HPV -26, was 
amplified for furt her studjes. 
HPV -26 DNA was excised from the vector by treatment with 
Ba m HI and purified by rate zonal centrifugation. The purified 
HPV -26 was labeled by nick translation and hybridized under 
strin gen t hybridization conditions to standard HPV DNAs on 
nitrocellulose filters (Fig 3). On ly a weak hybridization was 
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FI G 2. Hybridization of cellular DNA to HPV-3 and HPV-6. Equal 
amou nts of' total cellular DNA was electrophoresed, t ransferred to 
nitroce llulose filters, and hybridized under stringent condi t ions to 
laheled (A) I-IPV -:3 or (B) HPV -6, each labeled to about the same 
spec ific act ivity, followed by washing and autoradiography. La.n.es 1- .J : 
DNA extracts from each of the 4 tissue samples studied. La.n.e 5 : DN A 
extract of lane 1 was treated with a combination of Bam HI and Hind 
III restriction endonucleases. Form I DNA is where native superhelical 
viral DNA migrates, form 1 I where nicked, relaxed viral DNA migrates. 
and form. 1/1 where linear unit J en~:,rth viral DNA migrates. Slight 
variations in the migration of the na tive DNA forms ca n occur depend-
ing upon the quali ty and amount of total DNA extract applied to an\' 
one channel. Some faint bands are indi cat.ed with arrows. · 
detected with the la rge, and perhaps the s mall , Bam HI/ E co 
Rl fragments of HPV -6. This correlates well with the prelimi-
na ry hybridization data of the cellular DNA extracts. No sig-
nificant hybridization as observed under these conditions wi th 
HPV-1, -2 , -3, -4, -5, -7, -8, -10, HPV-P [18], HPV-PW [18], 
HPV-EV [4], or a n HPV-11 molecularly cloned in a similar 
fashion from a penile verrucous carcinoma [6; R. Ostrow, 
unpublished data]. Our HPV-11 DNA hybridized 100% by S1 
nuclease analysis and had a restriction endonuclease map sim-
ilar to that of HPV-11 obtained from L. Gissmann (19) . 
By currently accepted criteria [20], two HPV DNAs are 
considered to be of different types if they share less than 50% 
nucleotide sequence homology as measured by cross hybridi-
zation of the HPVs and analyzed with 81 nuclease. The rela-
tionship of HPV-26 to all of the above HPV DNA standards, 
with the exception of HPV-7 , -8 and -10, was tested by liqujd 
hybridizat ion fo llowed by Sl nuclease a nalysis. No hybridiza-
tion above 6% normalized was observed with any of these DNAs 
(data not shown). HPV-8, -12 , and to a lesser degree, HPV-9 
share simila r homology to HPV -5, and HPV -10 s hares signjfi -
cant nucleotide homology with HPV-3 [21- 24) . Very recently 
April1984 
we conducted stringent hybridization of HPV-26 with fully or 
partially molecularly cloned HPV-13 [25], HPV-16 and -18 
[26], and HPVs-9, -12, -14, -15, -17, and -19 to_ -2~ isolated 
from EV patients (G. Orth, personal commumcatwn). We 
observed no significant hybridization (data not shown). How-
ever, all of these HPV DNAs were not avai lable for in-depth 
comparative analysis at this time. HPV-25 isolated from an EV 
patient is not yet available for comparison, a lthough its restric-
tio n endonuclease map differs greatly from that of HPV-26 (G . 
Orth, p erso na l communication) (Fig 4). Based upon these re-
lationships, HPV -26 is unique and, under the criteria now used 
for typing HPVs [20], should be referred to as a separate HPV 
type. 
DISCUSSION 
Papillomas and associated neoplasias appear more prevalent 
in patients exhibiting immune deficiency syndromes. Whether 
HPV is a passenger virus in such cases or plays an etiologic 
role in t he immune deficiency remains to be determined. In 
t his case, we have isolated a previously undescribed HPV DNA 
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F IG 3. Hybridization of molecularly cloned HPV -26 to previously 
characterized HPV DNAs. Molecularly cloned HPV -26 DNA was ex-
cised from the vector DNA, labeled by nick transla tion and hybridized 
under stringent hybridization conditions to approximately 40 pg each 
of various sta ndard HPV DNAs (which had been excised from their 
respective vectors) on nitrocellulose fi lters as indicated. The molecular 
weight in megadaltons (MD) of the unit length HPV genome and that 
of t he 2 Bam Hl/Eco RI fragments of HPV -6 are shown on the right. 
T he smaller of the two fragments is just barely visible in this exposure. 
HPV-26 
0 
i ~ f;IH 
" " " 
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FIG 4. Rest riction endonuclease map of HPV -26. Molecularly 
clo ned HPV -26 was treated with restriction endonucleases individually 
or in combination, electrophoresed on agarose gels, and visualized 
either with ethidium bromide staining or by t ransfer to ni trocellu lose 
fi lters fo llowed by stringent hyb ridization to labeled HPV -26. Units 
represent percentage of the genome size with the unique Bam HI site 
as an arbitrary starting poin t. 
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many dist inctions remain, the lowered T-cell count and re-
versed helper/suppressor ratios a re quite similar to those ob-
served in patients with acquired immunodeficiency syndrome 
[27) . Recently, many new HPV-5 related subtypes as well as 
other distinct subtypes have been identified in EV patients (G. 
Orth and H . Pfister, personal communications). Our own stud-
iest have shown immune suppressed renal t ransplant patients 
to be a fflicted with papillomaviruses sharing nucleotide se-
quence homology with several different HPV DNA standard 
probes. It may be that in pat ients having immune difficiencies 
t here is a higher likelihood of mutational or recombinationa l 
events which lead to the formation of new HPV types. On t he 
other hand, t he immune defic iencies of these pat ients may 
permit t he infection and replication of human papillomaviruses 
that a re rare and have relat ively low infectious potential in the 
normal population. These rare viruses may also coincidently 
contain a higher oncogenic potential as witnessed by the in -
creased incidence of malignancies in EV and renal transplant 
patients. Based upon the correlation for some HPVs with 
immune defi ciencies and associated malign ancies [2,11- 14,26], 
it may be appropriate at t his t ime to examine malignancies and 
other tissues of immune deficient patients for the presence of 
HPVs like HPV -26. Alt hough there is no record t hat our patient 
had papillomas prior to his onset of cutaneous malignancies, 
we cannot rule out the possibility that a subclinical papilloma 
infection may have been present. Indeed, in apparently normal 
skin of patients with EV, we have observed t he presence of 
HPV-5 viral DNA (R. Ost row, unpublished data). It is also 
possible that t he radiat ion t reatments may have impa ired the 
pat ien t's immune system thus permitting t he various viral and 
microbial infections. The study of warts from patients with 
various immune deficiency syndromes may lead to t he discovery 
of many more diverse HPV variants. 
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